Ignite Creation Date:
2024-05-05 @ 9:09 PM
Last Modification Date:
2024-10-26 @ 10:00 AM
Study NCT ID:
NCT00829738
Status:
COMPLETED
Last Update Posted:
2012-05-08
First Post:
2009-01-13
Brief Title:
Efficacy of Pantoprazole 2040 mg Once Daily od in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease
Sponsor:
Nycomed
Organization:
Nycomed
Study Overview
Official Title:
Pantoprazole 2040 mg in Reflux-Associated Complaints With Focus on Gastrointestinal Symptoms
Status:
COMPLETED
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PARADE
Brief Summary:
The aim of this study was to evaluate the effect of 14 days treatment with Pantoprazole 40 mg and 20 mg on gastroesophageal reflux disease GERD related symptoms in a large patient population
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None